Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,364 | 400 | 99.8% |
| Education | $22.78 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $3,384 | 104 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,428 | 105 | $0 (2020) |
| Nevro Corp. | $1,156 | 31 | $0 (2024) |
| Medtronic USA, Inc. | $796.31 | 35 | $0 (2020) |
| Supernus Pharmaceuticals, Inc. | $321.18 | 21 | $0 (2020) |
| ACADIA Pharmaceuticals Inc | $315.42 | 18 | $0 (2024) |
| ABBVIE INC. | $267.67 | 16 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $196.18 | 10 | $0 (2021) |
| MDD US Operations, LLC | $195.45 | 8 | $0 (2024) |
| Biogen, Inc. | $162.19 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $936.84 | 26 | Nevro Corp. ($608.11) |
| 2023 | $2,085 | 55 | Medtronic, Inc. ($1,338) |
| 2022 | $1,838 | 61 | Medtronic, Inc. ($1,234) |
| 2021 | $1,027 | 50 | Medtronic, Inc. ($725.83) |
| 2020 | $350.95 | 22 | Medtronic USA, Inc. ($147.32) |
| 2019 | $724.39 | 36 | Medtronic USA, Inc. ($383.09) |
| 2018 | $900.30 | 53 | Sunovion Pharmaceuticals Inc. ($488.38) |
| 2017 | $1,525 | 101 | Sunovion Pharmaceuticals Inc. ($853.66) |
All Payment Transactions
404 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Neuropsychiatry | ||||||
| 10/14/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/14/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Neuropsychiatry | ||||||
| 08/15/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/13/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/10/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $38.47 | General |
| Category: AMANTADINE | ||||||
| 07/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Neuropsychiatry | ||||||
| 06/30/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $120.07 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/19/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: NEUROLOGY | ||||||
| 06/13/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/30/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/19/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $109.75 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/19/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $32.25 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/06/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $48.56 | General |
| Category: AMANTADINE | ||||||
| 03/27/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/20/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/06/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $86.88 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/21/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: AMANTADINE | ||||||
| 01/19/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $141.34 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/19/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $40.11 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/11/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/11/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Spinal Cord Stimulator | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 10,203 | 25,181 | $10.2M | $2.8M |
| 2022 | 49 | 9,656 | 24,036 | $9.3M | $2.7M |
| 2021 | 40 | 9,148 | 27,317 | $7.1M | $2.3M |
| 2020 | 45 | 9,330 | 44,023 | $6.7M | $1.9M |
All Medicare Procedures & Services
186 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 2,113 | 12,842 | $2.2M | $876,955 | 39.0% |
| 95713 | Measurement of brain wave activity with video (veeg), 2-12 hours with continuous monitoring | Office | 2023 | 341 | 973 | $1.5M | $435,846 | 29.9% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 341 | 974 | $974,000 | $212,661 | 21.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 625 | 652 | $488,800 | $206,368 | 42.2% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2023 | 806 | 812 | $625,240 | $151,886 | 24.3% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 806 | 811 | $883,990 | $139,819 | 15.8% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2023 | 806 | 812 | $625,240 | $111,415 | 17.8% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Office | 2023 | 341 | 973 | $243,250 | $101,374 | 41.7% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 413 | 415 | $228,250 | $90,810 | 39.8% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 69 | 197 | $242,450 | $49,523 | 20.4% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 273 | 277 | $290,850 | $46,673 | 16.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 262 | 264 | $145,200 | $42,281 | 29.1% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 207 | 356 | $243,300 | $35,209 | 14.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 289 | 337 | $75,825 | $32,051 | 42.3% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 181 | 181 | $190,050 | $29,651 | 15.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 282 | 282 | $63,450 | $24,316 | 38.3% |
| 70544 | Mri scan of blood vessels of head without contrast | Office | 2023 | 127 | 132 | $138,600 | $24,182 | 17.4% |
| 70547 | Mri scan of blood vessels of neck without contrast | Office | 2023 | 114 | 119 | $124,950 | $22,439 | 18.0% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 130 | 133 | $139,650 | $21,739 | 15.6% |
| 64479 | Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | Facility | 2023 | 78 | 146 | $109,750 | $15,002 | 13.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $21,750 | $10,923 | 50.2% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 149 | 263 | $98,625 | $10,661 | 10.8% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 54 | 55 | $27,500 | $9,584 | 34.9% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 84 | 182 | $27,200 | $9,530 | 35.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 341 | 1,644 | $24,660 | $9,518 | 38.6% |
About Dr. Sayed Monis, M.D
Dr. Sayed Monis, M.D is a Interventional Pain Medicine healthcare provider based in Brawley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942480231.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sayed Monis, M.D has received a total of $9,387 in payments from pharmaceutical and medical device companies, with $936.84 received in 2024. These payments were reported across 404 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($9,364).
As a Medicare-enrolled provider, Monis has provided services to 38,337 Medicare beneficiaries, totaling 120,557 services with total Medicare billing of $9.7M. Data is available for 4 years (2020–2023), covering 186 distinct procedure/service records.
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Neurology
- Location Brawley, CA
- Active Since 11/05/2007
- Last Updated 03/28/2019
- Taxonomy Code 208VP0014X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942480231
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $2,295
- APTIOM (Drug) $1,428
- INTELLIS (Device) $1,143
- Senza (Device) $1,115
- NUPLAZID (Drug) $315.42
- VANTA ADAPTIVESTIM (Device) $303.12
- RESTORE (Device) $263.14
- TROKENDI XR (Drug) $242.51
- UBRELVY (Drug) $207.14
- Qutenza (Drug) $162.00
- AUSTEDO (Drug) $141.01
- StimQ Receiver Stimulator Kit Channel A US w/Receiver (Device) $115.60
- NURTEC ODT (Drug) $106.94
- Gocovri (Drug) $103.02
- QULIPTA (Drug) $88.18
- INGREZZA (Drug) $87.72
- VALTOCO (Drug) $84.10
- OXTELLAR XR (Drug) $78.67
- GOCOVRI (Drug) $75.31
- TYSABRI (Biological) $73.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.